China Resources Pharmaceutical to Acquire Lier Chemical for $795M in Strategic Move into Agrochemical Sector

China Resources Pharmaceutical Group Limited (HKG: 3320) announced a definitive agreement to acquire 188,102,749 shares of Lier Chemical Co., Ltd. (SHE: 002258) at RMB 30.07 per share, representing a total transaction value of RMB 5,656,249,662.43 (approximately $795 million USD). The acquisition marks China Resources Pharmaceutical’s strategic entry into the agrochemical sector, expanding beyond its core pharmaceutical and healthcare distribution businesses.

Transaction Details

Target Company Profile

• Core Business: Research, development, production, and sales of pesticide active ingredients and formulations
• Product Focus: Highly effective, low-toxicity, low-residue, and safe agrochemical solutions
• Market Position: Established player in China’s agricultural chemicals market with 18+ years of public market experience
• Regulatory Compliance: Products designed to meet increasingly stringent environmental and safety standards in domestic and international markets
• Geographic Reach: Primarily China-focused with potential for export expansion through China Resources’ global network

Strategic Rationale & Market Context

The global agrochemical market is projected to reach $85 billion by 2028, driven by increasing food demand, limited arable land expansion, and the need for sustainable crop protection solutions. China’s agricultural sector represents one of the world’s largest markets for crop protection products, with growing emphasis on eco-friendly and residue-free formulations.

China Resources Group’s broader ecosystem includes significant interests in food retail, agriculture, and healthcare, creating natural synergies for vertical integration across the farm-to-table value chain. This acquisition aligns with China’s national priorities for food security, agricultural modernization, and environmental sustainability.

Key strategic benefits include:

• Diversification: Reduces reliance on pharmaceutical distribution margins through exposure to high-growth agrochemical segment
• Synergies: Leverages China Resources’ extensive logistics, distribution, and procurement networks for enhanced market penetration
• ESG Alignment: Supports development of safer, more sustainable agricultural practices through low-toxicity product portfolio
• Vertical Integration: Creates opportunities for integrated solutions spanning agricultural inputs to food safety and healthcare

Financial Implications

• Purchase Price: Represents approximately 15x forward earnings based on Lier Chemical’s recent financial performance
• Funding: Expected to be financed through combination of cash reserves and debt facilities
• Accretion Timeline: Transaction expected to be accretive to earnings within 24 months post-closing
• Integration Costs: Estimated RMB 200-300 million for operational integration and synergy realization

Next Steps

• Regulatory Approvals: Secure approvals from Chinese antitrust authorities and other relevant regulatory bodies
• Shareholder Approvals: Obtain necessary approvals from both companies’ shareholders as required under listing rules
• Integration Planning: Establish dedicated integration team to realize operational and commercial synergies
• Strategic Review: Evaluate potential product portfolio optimization and international expansion opportunities leveraging China Resources’ global presence

Forward‑Looking Statements
This brief contains forward-looking statements regarding the proposed acquisition, including timing, regulatory approvals, financial impact, and strategic benefits. Actual results may differ due to risks including regulatory delays, financing conditions, market volatility, and integration challenges.-Fineline Info & Tech